A Sensitive and Robust HPLC Assay with Fluorescence Detection for the Quantification of Pomalidomide in Human Plasma for Pharmacokinetic Analyses

Pomalidomide is a second generation IMiD (immunomodulatory agent) that has recently been granted approval by the Food and Drug Administration for treatment of relapsed multiple myeloma after prior treatment with two antimyeloma agents, including lenalidomide and bortezomib. A simple and robust HPLC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shahbazi, Shandiz, Peer, Cody J., Polizzotto, Mark N., Uldrick, Thomas S., Roth, Jeffrey, Wyvill, Kathleen M., Aleman, Karen, Zeldis, Jerome B., Yarchoan, Robert, Figg, William D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943695/
https://ncbi.nlm.nih.gov/pubmed/24486861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2014.01.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados